Quality Assurance Program
Regulatory Compliance
SeqWright developed and implemented a comprehensive Quality Assurance (QA) Program in 1999 to better support its growing base of pharma and biotech clients, with Quality Systems built around the Food & Drug Administration (FDA) guidelines described in section 21 of the Federal Code. These guidelines include regulations governing non-clinical Good Laboratory Practices (GLP), electronic signatures, and drug manufacturing. Additionally, SeqWright is CLIA certified for the receipt and analysis of patient samples.
With a myriad of regulatory submission quality projects completed and numerous successful facility audits occurring each year, SeqWright is uniquely positioned, with the required experience and expertise, to perform your GLP projects in the most efficient and timely manner possible.

Contact a sales representative about this Program. |